pyrroles has been researched along with Emesis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, S; Boix, O; Cassier, PA; Cathomas, R; Cho, BC; Ellinghaus, P; Gajate, P; Grevel, J; Joerger, M; Navarro, A; Nogai, H; Nogova, L; Ocker, M; Park, SH; Penel, N; Rajagopalan, P; Richly, H; Sayehli, CM; Schostak, M; Schuler, M; Soo, RA; Tai, D | 1 |
| Broder, MS; Chang, E; Neary, MP; Reddy, SR | 1 |
| Jackson, AE | 1 |
| Berardi, R; Burattini, L; Cascinu, S; Conti, A; De Giorgi, U; Iacovelli, R; Muzzonigro, G; Pantano, F; Santini, D; Santoni, M | 1 |
| Alkam, T; Chebolu, S; Darmani, NA; Vaezi, M; Zhong, W | 1 |
| Beniak, J; Kakalejcik, M; Reckova, M | 1 |
| Bergman, PJ; Boucher, JF; Couto, GC; Henry, CJ; Hintermeister, JG; Klein, MK; London, CA; Malpas, PB; Mauldin, GN; Michels, GM; Mitchener, KL; Rosenberg, MP; Rusk, AW; Wood-Follis, SL | 1 |
| Peters, GJ; Schneiders, FL; van den Berg, HP; van der Vliet, HJ; Verheul, HM | 1 |
| Bello, A; Burris, HA; Chao, R; Chiorean, EG; Jones, S; Lee, FC; Liau, KF; Royce, M; Sweeney, CJ; Tye, L; Verschraegen, CF | 1 |
| Cropp, G; Gosalia, R; Hannah, A; Sheldon, M; Stopeck, A; Vahedian, M | 1 |
| Calis, KA; Charney, DS; Cizza, G; Contoreggi, C; Curry, PT; Glaze, ER; Gold, PW; Harder, JB; Horn, TL; Johnson, WD; McCormick, DL; Mellick, PW; Morrissey, RL; Parchment, RE; Rice, KC; Tomaszewski, JE | 1 |
| Ito, H; Iwaoka, K; Kiso, T; Miyata, K; Naitoh, Y; Yamaguchi, T; Yuki, H | 1 |
| Bell, MR; Bradford, JC; Clemans, SD; Dumas, DJ; Oesterlin, R; Rozitis, J; Zalay, AW | 1 |
1 review(s) available for pyrroles and Emesis
| Article | Year |
|---|---|
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials.
Topics: Adverse Drug Reaction Reporting Systems; Carcinoma, Renal Cell; Clinical Trials as Topic; Diarrhea; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Incidence; Indazoles; Indoles; Liver Neoplasms; Neoplasms; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; Vomiting | 2014 |
3 trial(s) available for pyrroles and Emesis
| Article | Year |
|---|---|
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
Topics: Acute Kidney Injury; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Diarrhea; Fatigue; Female; Humans; Hyperphosphatemia; Hypoglycemia; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Piperazines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Thiophenes; Vomiting | 2019 |
A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Pyrroles; Sunitinib; Treatment Outcome; Vomiting; Young Adult | 2010 |
Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies.
Topics: Adult; Aged; Angiogenesis Inhibitors; Combined Modality Therapy; Endothelial Growth Factors; Fatigue; Female; Fibroblast Growth Factor 2; Headache; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Middle Aged; Molecular Structure; Nausea; Neoplasms; Pyrroles; Salvage Therapy; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vomiting | 2002 |
9 other study(ies) available for pyrroles and Emesis
| Article | Year |
|---|---|
Treatment Patterns and Burden of Illness in Patients Initiating Targeted Therapy or Chemotherapy for Pancreatic Neuroendocrine Tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cost of Illness; Everolimus; Humans; Indoles; Middle Aged; Molecular Targeted Therapy; Nausea; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Vomiting; Young Adult | 2017 |
In this issue - May 2019: West Nile virus in horses · Treating horses with dexamethasone via nebulisation · Animal hoarding in NSW · Dangers of powdered washing soda for emesis in dogs · Pneumocystis in a dog following toceranib phosphate · Oxalate nephro
Topics: Animals; Anti-Inflammatory Agents; Asthma; Dexamethasone; Dog Diseases; Dogs; Emetics; Hoarding; Horse Diseases; Horses; Indoles; Nebulizers and Vaporizers; Nephrosis; New South Wales; Oxalates; Phascolarctidae; Pneumocystis; Pneumocystis Infections; Powders; Pyrroles; Vomiting; West Nile Fever; West Nile virus | 2019 |
Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
Topics: Animals; Antiemetics; Calcium Channel Blockers; Calcium Channels, L-Type; Drug Synergism; Female; Isoquinolines; Male; Nifedipine; Palonosetron; Pyrroles; Quinuclidines; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Shrews; Vomiting | 2014 |
Treatment of hemodialyzed patient with sunitinib.
Topics: Anemia; Antineoplastic Agents; Carcinoma, Renal Cell; Coronary Artery Bypass; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Indoles; Male; Middle Aged; Nausea; Nephrectomy; Pyrroles; Remission Induction; Renal Dialysis; Sunitinib; Thrombocytopenia; Treatment Outcome; Vomiting | 2009 |
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
Topics: Animals; Anorexia; Diarrhea; Disease Progression; Dog Diseases; Dogs; Female; Indoles; Male; Mast-Cell Sarcoma; Neoplasm Recurrence, Local; Pyrroles; Random Allocation; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Vomiting | 2009 |
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Bisoprolol; Bone Neoplasms; Capecitabine; Colic; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Heptanoic Acids; Humans; Hypercholesterolemia; Ileus; Leucovorin; Lymphatic Metastasis; Middle Aged; Nausea; Pyrroles; Ventricular Premature Complexes; Vomiting | 2011 |
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist.
Topics: Animals; Bone Marrow Cells; Cell Line, Tumor; Colony-Forming Units Assay; Dogs; Female; Humans; Kidney; Liver; Male; Mice; Mutagenicity Tests; No-Observed-Adverse-Effect Level; Pyrimidines; Pyrroles; Rats; Rats, Inbred F344; Receptors, Corticotropin-Releasing Hormone; Salmonella typhimurium; Vomiting | 2008 |
Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets.
Topics: Animals; Citrates; Constipation; Defecation; Dose-Response Relationship, Drug; Feces; Ferrets; Male; Nausea; Organometallic Compounds; Picolines; Pyrroles; Serotonin Receptor Agonists; Thiazoles; Time Factors; Vomiting; Water | 2001 |
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
Topics: Animals; Anti-Ulcer Agents; Dogs; Gastric Juice; Guinea Pigs; Heart Rate; In Vitro Techniques; Indoles; Male; Mice; Pupil; Pyrroles; Rats; Structure-Activity Relationship; Vomiting | 1977 |